跳至主要内容
临床试验/CTRI/2024/06/068929
CTRI/2024/06/068929尚未招募4 期

Effectiveness And Safety of Nutritional Supplement Momordica Charantia in Type 2 Diabetes Mellitus:Randomised Open Label Study- PG Dissertation - NI

Kancherla Narasimha Abhinav Kaushal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with type 2 diabetes mellitus
  • Patients receiving two drugs (Sulfonylureas (Glimepiride) + Metformin) for a minimum period of 12 weeks
  • Patients with HbA1c 6.5 To 8%

排除标准

  • Patients with type 2 diabetes mellitus receiving insulin
  • Patients with liver dysfunction
  • Patients who are on treatment with either steroids or immunosuppressive agents
  • Pregnancy or Lactation
  • Patients with renal impairment

研究者

发起方
Kancherla Narasimha Abhinav Kaushal

相似试验